Clinical Trial Update: Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer [Phase 3]

View source ↗

Summary

A phase 3 trial comparing androgen deprivation therapy with SBRT versus SBRT alone for intermediate-risk prostate cancer was terminated, with results posted on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (ADT) (Androgen deprivation therapy)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED | Results posted: 2024-08-28